Investors have recently been faced with many headwinds in the first half of 2019. With potential threats to Bulls positions constantly surfacing, 2019 has been volatile to say the least. The most recent event investors need to pay attention to is within Brexit and the threats/opportunities that are becoming increasingly apparent. In this article I will discuss;
- Brexit and it’s implications for the market
- How you can position to mitigate exposure and maximize gains
- Potential opportunities created by Brexit
What Is The Impact?
Brexit has Britain considering leaving the European Union, opening the door to a massive influx in regulatory hurdles for firms. The impact of this action (if taken) is likely going to incite violent moves in financial markets. Britain leaving the EU will present countless businesses with additional regulatory hurdles and in some cases may wipe them out. This can be related to the state of California breaking off from the US. How would trade continue? Surely additional constraints will immediately commence upon a decision to leave. One of the opportunities businesses have taken advantage of in being part of the EU is “Passporting.” Passporting allows companies licensed in one EU member country to trade across borders with ease due to less regulatory requirements. The loss of this opportunity and other factors have led many analysts to place a $5 billion loss in investment within Britain over the next 5 years if the vote is successful. This concern has led to UK Banks stockpiling in anticipation of their clientele wishing to withdraw funds due to rising fears. Although these concerns are primarily placed with the EU and Britain, the impact has already reached US markets. Last week US markets observed what some argue to be a 5-day lull as reported by MarketWatch, as investors weigh out the various outcomes. In an article released by the Guardian, it is estimated that the S&P 500 would tank 5% with banking stocks taking an 8% hit. This leaves a 40% increase in volatility for the overall stock market. Although these are just forecasts, they provide investors with potential insights into the impact. With that in mind, these projections may leave additional downside that isn’t fully scaled into the calculations. The only thing that’s for certain with this decision is that investors need to protect portfolios from risk with the decision.
How Do I protect My Portfolio?
Let’s say Brexit goes through, how are you positioned? Shares of LABD (Direction Daily S&P Biotech Bear 3X Shares) saw a 5% increase in value yesterday as investors cash in on a potential pullback. LABD stands to benefit from a Bearish outlook on the markets, specifically biotech as recently inflated prices begin to be tested and pull back.
Coming off of highs around $60 in December, investors confidence has seemed to increase in a short term view with both a recent run from the markets and potential bearish events. Investors are also happy to find a potential rejection of price levels in the $16 range, suggesting a short term run to $18-21. Once in this range, it will be wise to assess sentiment on the outcome of Brexit & other factors impacting the markets for a healthy exit. This places LABD with a short term speculative price target of $18-21 for a potential exit. This reassessment is key to maximizing return due to the nature of returns swaps.
If Brexit goes in a favorable vote by the market’s interpretation, we can likely anticipate a bit of “short squeeze.” Many people are bullish on some of Britains fundamentals in the past years such as their GDP growth rate coming in at 1.8% for the year in 2017. Britain has remained competitive in the global economy and showed many signs of growth, but Brexit is sure to negatively skew some of these measures. If this event doesn’t take the catastrophic route many are preparing for, we may see a bullish push as faith is restored in prices. Last week provided investors with a unique lens into the US markets take on Brexit as it remained rather stagnant in anticipation of a decision. Should the news be perceived as bullish (remaining in the EU), prices will likely find a healthy rally to combat the negative sentiment running up to the event. Should this vote go in favor of remaining in the EU, shares of
Brexit presents many risks to financial markets, but in turn presents a great deal of opportunity to investors prepared to position accordingly. A vote to leave the EU will impact countless industries who rely on the ease of commerce presented by EU membership. The impact will be felt further than directly impacted industries as investors witnessed in the previous “flat” trading week, which saw investors of both sides waiting for a clearer direction. Analysts have forecasted sizable downside from a vote to leave the EU, such as a potential -5% drop to the S&P 500 and downside & volatility for other related fields. This potential downside presents opportunity to investors through LABD, a biotech ETF taking a bearish perspective. Shares closed today (4/9/19) up 5%, but suggest further upside as fears persist. Although many factors indicate upside being imminent, there is a great deal of risk involved in holding through the upcoming vote. For a further technical view on the bullish thesis for LABD click here.
MS Money Move and its Chief Operating Officer who is a scientist and individual investor, as well as its affiliates are not registered financial advisors. Our posts should serve as educational material to help you conduct due diligence research. Posts and articles are not directives or recommendations to invest in any security. We reserve the right to buy or sell any security for ourselves without any notification except when required by law. We are not responsible for the action of our affiliates. Investment theses may change due to the variable nature of the securities market. Because of this there is great risk when investing in stocks and options which can result is capital loss. Additionally, past performance by MS Money Moves or any security is not a predictor of future performance. Everyone should conduct their own research and due diligence before making an investment decision. We recommend you consult a financial advisor regarding any investment action.
The biotech sector is especially volatile. Stock prices may fluctuate substantially based on material or nonmaterial developments. We encourage everyone to familiarize themselves with clinical trial processes, relevant terminology, FDA/SEC rules and regulations, and the general processes of drug & therapy development/approval. Always do independent research in a security prior to investing.